Core Viewpoint - The company, through its subsidiary Beijing Zhijingling Technology Co., Ltd., is participating in a national major science and technology project focused on the diagnosis and treatment of cognitive disorders related to intracranial atherosclerotic stenosis (ICAS) [1][2][3] Group 1: Project Overview - The national major science and technology project aims to address the diagnostic challenges of ICAS-related cognitive disorders by developing a comprehensive assessment technology system and deep reasoning predictive models [2] - The project is led by Xuanwu Hospital and involves collaboration with several prestigious institutions, including the Chinese Academy of Medical Sciences and Jilin University, bringing together top experts from neurology, cognitive neuroscience, psychology, and artificial intelligence [2][3] Group 2: Company Role and Contributions - The company will leverage its expertise in digital diagnosis and treatment of neurological and psychiatric disorders to develop deep reasoning models and digital treatment platforms for ICAS-related cognitive disorders [3] - The newly established Beijing Key Laboratory for Digital Therapy of Cognitive Disorders will integrate clinical medicine, basic research, technology development, and hardware innovation, with the company playing a key role in algorithm development and user experience optimization [3]
脑动极光-B(06681)：参与国家科技重大专项研究课题及获批认知障碍数字医疗北京市重点实验室